A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model

The blockade of programmed cell death-1 (PD1) and its ligand PDL1 has been proven to be a successful immunotherapy against several cancers. Similar to cancer, PD1 contributes to the establishment of several chronic infectious diseases, including malaria. While monoclonal antibodies (mAbs) targeting...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Immunol
Huvudupphovsmän: Phares, Timothy W., Kotraiah, Vinayaka, Karunarathne, Deshapriya S., Huang, Jing, Browne, Cecille D., Buontempo, Peter, Mansour, Marc, Noe, Amy R., Wykes, Michelle N., Pannucci, James, Tsuji, Moriya, Gutierrez, Gabriel M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2020
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7363839/
https://ncbi.nlm.nih.gov/pubmed/32733457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01377
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk